Correlation Between Regeneron Pharmaceuticals and JPMORGAN

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and JPMORGAN at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and JPMORGAN into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and JPMORGAN CHASE CO, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and JPMORGAN and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of JPMORGAN. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and JPMORGAN.

Diversification Opportunities for Regeneron Pharmaceuticals and JPMORGAN

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Regeneron and JPMORGAN is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and JPMORGAN CHASE CO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on JPMORGAN CHASE CO and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with JPMORGAN. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of JPMORGAN CHASE CO has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and JPMORGAN go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and JPMORGAN

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 1.49 times less return on investment than JPMORGAN. In addition to that, Regeneron Pharmaceuticals is 7.26 times more volatile than JPMORGAN CHASE CO. It trades about 0.01 of its total potential returns per unit of risk. JPMORGAN CHASE CO is currently generating about 0.07 per unit of volatility. If you would invest  8,917  in JPMORGAN CHASE CO on August 31, 2024 and sell it today you would earn a total of  467.00  from holding JPMORGAN CHASE CO or generate 5.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.93%
ValuesDaily Returns

Regeneron Pharmaceuticals  vs.  JPMORGAN CHASE CO

 Performance 
       Timeline  
Regeneron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
JPMORGAN CHASE CO 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days JPMORGAN CHASE CO has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, JPMORGAN is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Regeneron Pharmaceuticals and JPMORGAN Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regeneron Pharmaceuticals and JPMORGAN

The main advantage of trading using opposite Regeneron Pharmaceuticals and JPMORGAN positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, JPMORGAN can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in JPMORGAN will offset losses from the drop in JPMORGAN's long position.
The idea behind Regeneron Pharmaceuticals and JPMORGAN CHASE CO pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk